Rapid Sterility Testing Research Report by Product, Technology (Membrane Filtration, ATP Bioluminesc
- sagar joshi
- Nov 19, 2018
- 1 min read
Some of the prominent players in the global rapid sterility testing market are Charles River Laboratories, Inc. (US), Gibraltar Laboratories (US), Merck KGaA (Germany), Rapid Micro Biosystems, Inc. (US), bioMérieux (France), Eurofins Scientific (Luxembourg), Becton, Dickinson and Company (US), FOCUS Laboratories (US), Sartorius AG (Germany), and Thermo Fisher Scientific (US).
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/rapid-sterility-testing-market-6621
Increasing R&D expense and new product launches are expected to drive the growth of the market. According to the Center for Drug Evaluation and Research, in 2017, about 46 novel drug approvals were the 22 novel drug approval in 2016. On the other hand, the availability of the alternative traditional method can restrain the market growth over the assessment period.
Market Segmentation
The global rapid sterility testing market has been segmented into product, technology, and application.
Based on product, the market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to account for the largest share and fastest growing segment of the global market in 2017.
Based on technology, the market is segmented into membrane filtration, ATP bioluminescence, and others. The ATP bioluminescence segment is expected to account for the largest share segment of the global market in 2017.
Based on application, has been segmented into pharmaceutical and biological manufacturing, medical device manufacturing, other end users.
Intended Audience
Rapid sterility testing Manufacturers and vendors
Rapid sterility testing service providers
Various research and consulting firms
Pharmaceutical and Biotech companies
Medical device companies
Comments